Physician profile
Debra Greenfield
NPI 1558525964
$2,403.95
in general payments reported to CMS, 2019-2025
11 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $257 · 2021: $308 · 2022: $263 · 2023: $457 · 2024: $379 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $508.32 | 2022-2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Vivus LLC | $507.15 | 2019-2025 | Qsymia |
| Novo Nordisk INC | $479.67 | 2019-2025 | Wegovy, Saxenda |
| Currax Pharmaceuticals LLC | $331.43 | 2019-2025 | Contrave |
| Lilly USA, LLC | $216.85 | 2021-2025 | Zepbound, Jardiance, Mounjaro |
| Eisai INC. | $195.88 | 2019 | |
| Bausch Health US, LLC | $56.18 | 2021-2022 | |
| Nalpropion Pharmaceuticals LLC | $48.61 | 2019 | |
| Abbott Laboratories | $24.68 | 2023 | Freestyle Libre 2 |
| Medicomp INC | $17.66 | 2025 | Telepatch Cardiac Monitor |
| Arbor Pharmaceuticals, INC. | $17.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Greenfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.